Overview
Matrixyl 3000 combines two palmitoylated signal peptides that target dermal fibroblasts to upregulate extracellular matrix protein synthesis.
- Cosmetic ingredient supplier
- Topical serums and creams
Mechanism of action
Mimics endogenous matrikine signals from collagen breakdown, prompting fibroblasts to synthesize collagen, elastin, and hyaluronic acid.
- · Matrikine signaling
- · Fibroblast activation
- · Collagen I and III synthesis
How it acts on the body
When collagen breaks down with age, small fragments act as 'matrikines' that signal repair. Matrixyl 3000 mimics those fragments, prompting fibroblasts to deposit fresh ECM proteins without injury or inflammation.
Topical penetration is the limiting factor; palmitoylation improves it but absolute uptake into the dermis is modest. Realistic outcomes are gradual improvement in skin firmness and fine line depth over months of consistent use.
Hormonal & endocrine impact
How this peptide is reported to shift specific hormones and signaling molecules. Directionality reflects research literature and preclinical models, not clinical prescribing data.
Curves are schematic shapes (sigmoid for increases/decreases, damped oscillation for modulation/stabilization) anchored to a 100% baseline. They communicate direction and tempo of change reported in research literature — not absolute hormone concentrations.
Effects on the body
Organ system effects
Dermal fibroblast activation.
None.
Reported effects
Drawn from preclinical research, anecdote, and small-scale clinical observation. No evidence grades are assigned — most peptides on this page lack rigorous human trials.
- Gentle, well-tolerated mechanism
- Complements retinoid use
Potential side effects
- · Mild irritation
- · Contact dermatitis
- · None documented
Drug interactions
No notable interactions reported.
Pairing context
- Sunscreen, retinoid, and vitamin CCombined prevention plus signaling support.
- Active inflammatory skin diseaseDefer until barrier is restored.